Eventide Asset Management - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2015$6,593,000
+173.3%
420,500
+83.8%
0.33%
+135.7%
Q3 2015$2,412,000
-66.9%
228,800
-20.7%
0.14%
-64.5%
Q2 2015$7,281,000
-9.5%
288,7000.0%0.39%
-34.9%
Q1 2015$8,046,000
+52.7%
288,7000.0%0.60%
+5.2%
Q4 2014$5,269,000
+40.8%
288,7000.0%0.58%
+10.2%
Q3 2014$3,742,000
-20.6%
288,7000.0%0.52%
-18.6%
Q2 2014$4,712,000
-7.6%
288,7000.0%0.64%
-19.1%
Q1 2014$5,101,000
-18.0%
288,700
+12.3%
0.79%
-58.7%
Q4 2013$6,222,000257,0001.92%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2013
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 1,025,000$24,815,00031.36%
TSP Capital Management Group, LLC 836,342$20,248,0008.80%
Iguana Healthcare Management, LLC 200,000$4,842,0002.76%
First Light Asset Management, LLC 116,096$2,811,0002.38%
SECTORAL ASSET MANAGEMENT INC 2,227,688$53,932,0002.33%
BENNETT LAWRENCE MANAGEMENT L L C/NY 550,735$13,334,0002.05%
Eventide Asset Management 257,000$6,222,0001.92%
Redmile Group, LLC 397,951$9,634,0001.19%
ARDSLEY ADVISORY PARTNERS LP 357,000$8,643,0001.15%
Rhenman & Partners Asset Management AB 90,000$2,179,0000.85%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders